A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS 1535 in Patients With Mild to Severe Scalp Psoriasis
Phase of Trial: Phase III
Latest Information Update: 12 May 2017
At a glance
- Drugs Desoximetasone (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 04 May 2017 Status changed from active, no longer recruiting to completed.
- 16 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Mar 2017.
- 16 Mar 2017 Status changed from recruiting to active, no longer recruiting.